Today, we're sharing an enlightening article that delves into the profound challenges of China's pharmaceutical sector—challenges that run deeper than those faced by other US-targeted industries like semiconductors, yet often overlooked by investors and policymakers. The article prompts us to consider:
I had no idea there was such a large trade gap between China and the US for pharmaceuticals. It's funny because when the COVID crisis started there was urgency in the US to de-risk pharmaceutical supply chains from China. Are there any other big high-level industries where the China-US trade gap is this large?
I had no idea there was such a large trade gap between China and the US for pharmaceuticals. It's funny because when the COVID crisis started there was urgency in the US to de-risk pharmaceutical supply chains from China. Are there any other big high-level industries where the China-US trade gap is this large?